Advances in mesenchymal stem cells therapy for tendinopathies / 中华创伤杂志(英文版)
Chinese Journal of Traumatology
;
(6): 11-17, 2024.
Artículo
en Inglés
| WPRIM
| ID: wpr-1009506
ABSTRACT
Tendinopathies are chronic diseases of an unknown etiology and associated with inflammation. Mesenchymal stem cells (MSCs) have emerged as a viable therapeutic option to combat the pathological progression of tendinopathies, not only because of their potential for multidirectional differentiation and self-renewal, but also their excellent immunomodulatory properties. The immunomodulatory effects of MSCs are increasingly being recognized as playing a crucial role in the treatment of tendinopathies, with MSCs being pivotal in regulating the inflammatory microenvironment by modulating the immune response, ultimately contributing to improved tissue repair. This review will discuss the current knowledge regarding the application of MSCs in tendinopathy treatments through the modulation of the immune response.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Diferenciación Celular
/
Células Madre Mesenquimatosas
/
Inflamación
Límite:
Humanos
Idioma:
Inglés
Revista:
Chinese Journal of Traumatology
Año:
2024
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS